Emerging Infectious Diseases Institute

Emerging Infectious Diseases Institute
Name	Emerging Infectious Diseases Institute
Type	Research institute
Location	Atlanta, Geneva, Nairobi
Established	2000s
Focus	Infectious disease research, epidemiology, public health
Director	Medical and scientific leadership

Emerging Infectious Diseases Institute. The Emerging Infectious Diseases Institute is a multidisciplinary research and public health organization focused on detection, prevention, and control of novel and re-emerging pathogens. The institute links laboratory science, clinical investigation, and field epidemiology through collaborations with academic centers, international agencies, and national ministries of health. Its work interfaces with global health security, outbreak response, and translational science to inform policy, surveillance, and clinical care.

Overview

The institute integrates laboratory capacity building with epidemiologic surveillance, leveraging networks such as Centers for Disease Control and Prevention, World Health Organization, Pan American Health Organization, African Union public health entities, and academic partners like Johns Hopkins University, Harvard University, University of Oxford, London School of Hygiene & Tropical Medicine, and University of California, San Francisco. It operates sentinel surveillance and reference laboratories aligned with standards from Food and Drug Administration clearance processes, European Centre for Disease Prevention and Control guidelines, and Global Health Security Agenda objectives. The institute provides policy-relevant evidence used by ministries such as Ministry of Health (Kenya), Ministry of Health (Uganda), and Ministry of Health and Family Welfare (India) during responses to events including Ebola virus epidemic in West Africa, COVID-19 pandemic, Zika virus epidemic, and outbreaks of Middle East respiratory syndrome coronavirus.

History and Development

Founded in the 2000s amid concerns following the Severe acute respiratory syndrome outbreak, the institute drew early support from philanthropic organizations like the Bill & Melinda Gates Foundation and international funders such as United States Agency for International Development, Wellcome Trust, and Global Fund to Fight AIDS, Tuberculosis and Malaria. Early programs were informed by lessons from historic events including the 1918 influenza pandemic, the HIV/AIDS pandemic, and the SARS epidemic and shaped by regulatory frameworks exemplified by the International Health Regulations (2005). Leadership recruited investigators with prior roles at institutions like Centers for Disease Control and Prevention, National Institutes of Health, Pasteur Institute, and Walter Reed Army Institute of Research, enabling rapid growth into a hub for outbreak research and field trials connected to initiatives such as PREDICT (USAID) and Coalition for Epidemic Preparedness Innovations.

Research Programs and Priorities

Research themes include viral emergence, bacterial antimicrobial resistance, zoonotic spillover, vector-borne disease, and diagnostic innovation. Programs collaborate with vaccine developers at Moderna, Inc., Pfizer, and GSK and therapeutics groups at Merck & Co., Roche, and Gilead Sciences to evaluate candidate interventions in clinical trials governed by ethics boards such as Institutional Review Board structures and guided by Declaration of Helsinki principles. Laboratory science spans genomics with platforms from Illumina, pathogen discovery informed by work at the Broad Institute, and bioinformatics approaches used by teams from European Bioinformatics Institute. Projects analyze data using standards from The Lancet-published protocols and contribute to consortia like Global Virome Project and Human Microbiome Project.

Clinical and Public Health Activities

The institute conducts clinical cohort studies, randomized controlled trials, and observational surveillance linked to hospital systems such as Mayo Clinic, Massachusetts General Hospital, and referral centers in partner countries. Field epidemiology training is coordinated with programs like Field Epidemiology Training Program and outbreak response exercises with United Nations Office for the Coordination of Humanitarian Affairs and Médecins Sans Frontières. Public health outputs inform vaccination campaigns coordinated with Gavi, the Vaccine Alliance and antimicrobial stewardship aligned with World Organisation for Animal Health recommendations. During emergencies the institute supports laboratory confirmation, contact tracing, and case management protocols used in responses to Lassa fever, Chikungunya, and novel influenza A strains.

Education, Training, and Capacity Building

Capacity building efforts include postgraduate training, short courses in genomic epidemiology developed with National Institutes of Health, and fellowship exchanges with universities like Columbia University and University of Toronto. Training curricula draw on methods from Ebola vaccine trial in Guinea and surveillance frameworks from Integrated Disease Surveillance and Response to strengthen national laboratory systems consistent with Global Health Security Agenda metrics. The institute hosts workshops for laboratory technicians, clinicians, and policy-makers that incorporate guidance from World Health Organization technical programs and case studies involving agencies such as UNICEF and Red Cross societies.

Partnerships and Collaborations

Partnership networks include bilateral research agreements with ministries exemplified by Ministry of Health (Ghana), consortia such as African Centres for Disease Control and Prevention, and university alliances including Imperial College London and University of Cambridge. Collaborative projects have been conducted with international organizations like World Bank health programs, philanthropic donors such as Wellcome Trust, and corporate partners in diagnostics and pharmaceuticals. The institute participates in data-sharing platforms coordinated with GISAID, specimen banking aligned with International Society for Biological and Environmental Repositories, and policy forums convened by World Health Assembly delegates.

Funding and Governance

Funding streams combine grants from international funders including Bill & Melinda Gates Foundation, contracts from United States Agency for International Development, research awards from National Institutes of Health, and philanthropic gifts. Governance structures involve boards composed of experts formerly affiliated with Centers for Disease Control and Prevention, National Institutes of Health, World Health Organization, European Commission, and academic leaders from Johns Hopkins University and London School of Hygiene & Tropical Medicine. Financial oversight follows standards promoted by International Monetary Fund and audit practices used by major non-governmental organizations such as Oxfam and Save the Children.

Category:Infectious disease organizations